Vimarsana
Biggest News Aggregation in the World

Eisai Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eisai Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eisai Co Today - Breaking & Trending Today

Making it easier to fly more than one airline to your destination - Vimarsana News

Making it easier to fly more than one airline to your destination

Stories you may have missed from the world of business.

Study uses blood tests to detect early-stage Alzheimer's in Japanese - Vimarsana News

Study uses blood tests to detect early-stage Alzheimer's in Japanese

A research team at the University of Tokyo says it has detected accumulations of proteins believed to cause Alzheimer's in blood samples taken from Japanese people with mild or no symptoms, potentially allowing easier and earlier detection of the disease.

Adlai Nortye Announces First Patient Dosed in Randomized Phase Ii Clinical Trial of Palupiprant for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy - Vimarsana News

Adlai Nortye Announces First Patient Dosed in Randomized Phase Ii Clinical Trial of Palupiprant for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy

Adlai Nortye Ltd. announced that the first patient was dosed in the Phase II clinical trial known as ARTEMIS . This clinical study evaluates palupiprant , a small molecule prostaglandin E receptor 4 ...

Epilepsy Treatment Market To Surpass USD 13.4 Billion By 2032, With 7.7% | Marketresearch.Biz Report - Vimarsana News

Epilepsy Treatment Market To Surpass USD 13.4 Billion By 2032, With 7.7% | Marketresearch.Biz Report

Marketresearch.biz reports that the Epilepsy Treatment Market size is expected to be worth around USD 13.4 Bn by 2032 from USD 6.5 Bn in 2022, growing at a CAGR of 7.7% during the forecast period from 2023 to 2032.Overview of the Epilepsy Treatment MarketThe Epilepsy Treatment Market focuses on providing therapeutic...

CNX Therapeutics to expand CNS portfolio through the acquisition of two established brands from Eisai - Vimarsana News

CNX Therapeutics to expand CNS portfolio through the acquisition of two established brands from Eisai

Eisai London, April 2nd, 2024 - CNX Therapeutics Limited (“CNX Therapeutics”), a speciality pharmaceutical company with a portfolio of medicines for the treatment of central nervous system (CNS) disorders and hospital emergencies in over 40 countries worldwide, is pleased to announce that it has suc...